Sometimes a great notion - An assessment of neoadjuvant systemic therapy for breast cancer

被引:23
作者
Davidson, NE
Morrow, M
机构
[1] Johns Hopkins Kimmel Canc Ctr, Baltimore, MD 21231 USA
[2] Fox Chase Canc Ctr, Philadelphia, PA 19111 USA
关键词
D O I
10.1093/jnci/dji049
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:159 / 161
页数:3
相关论文
共 14 条
[1]   The effect on tumor response of adding sequential preoperative docetaxel to preoperative doxorubicin and cyclophosphamide: Preliminary results from national surgical adjuvant breast and bowel project protocol B-27 [J].
Bear, HD ;
Anderson, S ;
Brown, A ;
Smith, R ;
Mamounas, EP ;
Fisher, B ;
Margolese, R ;
Theoret, H ;
Soran, A ;
Wickerham, DL ;
Wolmark, N .
JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (22) :4165-4174
[2]  
Bear HD, 2004, BREAST CANCER RES TR, V88, pS16
[3]   Effect of preoperative chemotherapy on the outcome of women with operable breast cancer [J].
Fisher, B ;
Bryant, J ;
Wolmark, N ;
Mamounas, E ;
Brown, A ;
Fisher, ER ;
Wickerham, DL ;
Begovic, M ;
DeCillis, A ;
Robidoux, A ;
Margolese, RG ;
Cruz, AB ;
Hoehn, JL ;
Lees, AW ;
Dimitrov, NV ;
Bear, HD .
JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (08) :2672-2685
[4]   Pathobiology of preoperative chemotherapy - Findings from the National Surgical Adjuvant Breast and Bowel Project (NSABP) protocol B-18 [J].
Fisher, ER ;
Wang, JP ;
Bryant, J ;
Fisher, B ;
Mamounas, E ;
Wolmark, N .
CANCER, 2002, 95 (04) :681-695
[5]   Locally advanced breast carcinoma: Accuracy of mammography versus clinical examination in the prediction of residual disease after chemotherapy [J].
Helvie, MA ;
Joynt, LK ;
Cody, RL ;
Pierce, LJ ;
Adler, DD ;
Merajver, SD .
RADIOLOGY, 1996, 198 (02) :327-332
[6]   International expert panel on the use of primary (Preoperative) systemic treatment of operable breast cancer: Review and recommendations [J].
Kaufmann, M ;
von Minckwitz, G ;
Smith, R ;
Valero, V ;
Gianni, L ;
Eiermann, W ;
Howell, A ;
Costa, SD ;
Beuzeboc, P ;
Untch, M ;
Blohmer, JU ;
Sinn, HP ;
Sittek, R ;
Souchon, R ;
Tulusan, AH ;
Volm, T ;
Senn, HJ .
JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (13) :2600-2608
[7]   A reduction in the requirements for mastectomy in a randomized trial of neoadjuvant chemoendocrine therapy in primary breast cancer [J].
Makris, A ;
Powles, TJ ;
Ashley, SE ;
Chang, J ;
Hickish, T ;
Tidy, VA ;
Nash, AG ;
Ford, HT .
ANNALS OF ONCOLOGY, 1998, 9 (11) :1179-1184
[8]   Monitoring response to primary chemotherapy in breast cancer using dynamic contrast-enhanced magnetic resonance imaging [J].
Martincich, L ;
Montemurro, F ;
De Rosa, G ;
Marra, V ;
Ponzone, R ;
Cirillo, S ;
Gatti, M ;
Biglia, N ;
Sarotto, I ;
Sismondi, P ;
Regge, D ;
Aglietta, M .
BREAST CANCER RESEARCH AND TREATMENT, 2004, 83 (01) :67-76
[9]  
MAURI D, 1935, J NATL CANCER I, V97, P18
[10]   Accuracy of MRI in the detection of residual breast cancer after neoadjuvant chemotherapy [J].
Rosen, EL ;
Blackwell, KL ;
Baker, JA ;
Soo, MS ;
Bentley, RC ;
Yu, DH ;
Samulski, TV ;
Dewhirst, MW .
AMERICAN JOURNAL OF ROENTGENOLOGY, 2003, 181 (05) :1275-1282